Adherence to Different Exercise Interventions

Sponsor
California Polytechnic State University-San Luis Obispo (Other)
Overall Status
Recruiting
CT.gov ID
NCT06024577
Collaborator
(none)
60
1
3
58.4
1

Study Details

Study Description

Brief Summary

Only 50% of sedentary adults that start an exercise training program adhere to the program after 6 months. Exercise variety may improve adherence. The goal of this study is to examine different exercise interventions that include a variety of exercise on adherence.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Walking
  • Behavioral: Variety
  • Behavioral: Progressive
N/A

Detailed Description

Regular exercise, in the form of walking 150 minutes per week, is widely regarded as having many health and fitness benefits. Despite these well-known benefits, adherence to exercise interventions is extremely low. When sedentary adults start an exercise training program only 50% adhere to the program and meet the national recommendations of 150 minutes per week. A possible explanation of the low adherence is that most adults only walk for exercise, and that providing a variety of exercise may increase adherence. Preliminary observational data show that a variety of exercise may increase weekly exercise expenditure compared to other interventions. The overall objective of this study is to investigate the feasibility, adherence, and acceptability of different exercise interventions including 1) walk intervention, 2) variety intervention, and 3) progressive intervention (see below for description).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized study to three arms: 1) walk intervention, 2) variety intervention, 3) progressive interventionRandomized study to three arms: 1) walk intervention, 2) variety intervention, 3) progressive intervention
Masking:
Single (Outcomes Assessor)
Masking Description:
Research staff collecting data will be masked to intervention
Primary Purpose:
Treatment
Official Title:
Aherence to Different Exercise Interventions
Actual Study Start Date :
Aug 18, 2023
Anticipated Primary Completion Date :
Jul 1, 2027
Anticipated Study Completion Date :
Jul 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Walking

Participants prescribed 150 minutes/week of moderate to vigorous walking.

Behavioral: Walking
Prescribed 150 minutes per week of moderate to vigorous walking.

Experimental: Variety

Participants prescribed 150 minutes/week of moderate to vigorous variety of exercise. Each week participants will be prescribed a single different exercise (variety) which will include cycling, walking/jogging, yoga/Pilates, and cross-training.

Behavioral: Variety
Prescribed 150 minutes per week of moderate to vigorous variety of exercise. Each week participants are randomly asked to participate in cycling, walking/jogging, yoga/Pilates, or cross-training.

Experimental: Progressive

Participants prescribed 150 minutes/week of moderate to vigorous exercise. The exercises include cycling, walking/jogging, yoga/Pilates, and cross-training, and each week another exercise will be added to the list of options for participants. Participants may choose from the list of exercise. They do not have to do them all, and they can do as much or little (none) of whatever they choose.

Behavioral: Progressive
Prescribed 150 minutes per week of moderate to vigorous progressive variety of exercise. Each week participants are randomly asked to participate in cycling, walking/jogging, yoga/Pilates, or cross-training. Participants can choose which exercise they want to do, and can do as much or little as they want.

Outcome Measures

Primary Outcome Measures

  1. Adherence to exercise intervention [Change from baseline at 1-week, 2-weeks, 3-weeks, and 4-weeks]

    Adherence is assessed as meeting or exceeding 150 minutes per week of moderate to vigorous exercise

Secondary Outcome Measures

  1. Acceptability of intervention [Acceptability at 4-weeks]

    Participants will complete a survey on acceptability at the end of the exercise intervention

  2. Body Weight [Change in body weight from baseline to 4-weeks]

    Body weight will be measured at baseline and 4-weeks

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-40 years old

  • Sedentary (<1 hour per week of exercise)

  • BMI 18.5 to 40 kg/m2

Exclusion Criteria:
  • Adults with diagnosed cardiovascular, diabetes, renal, or any other metabolic disease determined by Health and Fitness History questionnaire.

  • Any other disability, ailment, or physical characteristics that may hinder the ability to participate in regular exercise determined by Health and Fitness History questionnaire.

  • Participating in other studies that would interfere with their ability to safely complete the exercise protocols.

  • Pregnant or trying to become pregnant, and peri-menopausal or post-menopausal women.

  • History of smoking within the last 6 months

  • Any other vulnerable population (children <18, pregnant women, prisoners, etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 California Polytechnic State University San Luis Obispo California United States 93407

Sponsors and Collaborators

  • California Polytechnic State University-San Luis Obispo

Investigators

  • Principal Investigator: Todd Hagobian, California Polytechnic State University-San Luis Obispo

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Todd Hagobian, Chair and Professor, California Polytechnic State University-San Luis Obispo
ClinicalTrials.gov Identifier:
NCT06024577
Other Study ID Numbers:
  • 2023-152
First Posted:
Sep 6, 2023
Last Update Posted:
Sep 6, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 6, 2023